SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001079973-21-000871
Filing Date
2021-08-27
Accepted
2021-08-27 16:16:51
Documents
65

Document Format Files

Seq Description Document Type Size
1 FORM S-1 cbgl_s1-082021.htm S-1 2091012
2 EXHIBIT 5.1 ex5x1.htm EX-5.1 8333
3 EXHIBIT 23.1 ex23x1.htm EX-23.1 4075
4 EXHIBIT 10.64 CONVERTIBLEPROMISSORY NOTE DATED JULY 8, 2021 (EDWARD MANOLOS) ex10x64.htm EX-10.64 29849
5 EXHIBIT 10.65 - CONVERTIBLE PROMISSORY NOTE DATED JULY 8, 2021 (DAN VAN NGUYEN) ex10x65.htm EX-10.65 25321
  Complete submission text file 0001079973-21-000871.txt   6534750

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cbgl-20210531.xml EX-101.INS 901513
7 XBRL SCHEMA FILE cbgl-20210531.xsd EX-101.SCH 53335
8 XBRL CALCULATION FILE cbgl-20210531_cal.xml EX-101.CAL 62320
9 XBRL DEFINITION FILE cbgl-20210531_def.xml EX-101.DEF 224160
10 XBRL LABEL FILE cbgl-20210531_lab.xml EX-101.LAB 305180
11 XBRL PRESENTATION FILE cbgl-20210531_pre.xml EX-101.PRE 305001
Mailing Address 520 S. GRAND AVENUE SUITE 320 LOS ANGELES CA 90071
Business Address 520 S. GRAND AVENUE SUITE 320 LOS ANGELES CA 90071 (310) 986-4929
CANNABIS GLOBAL, INC. (Filer) CIK: 0001413488 (see all company filings)

IRS No.: 831754057 | State of Incorp.: NV | Fiscal Year End: 0831
Type: S-1 | Act: 33 | File No.: 333-259126 | Film No.: 211219112
SIC: 2836 Biological Products, (No Diagnostic Substances)